A New York-based biotech company is turning heads on Tuesday after it announced it signed a material transfer agreement to supply SLS-002 for the Department of Defense’s...

To read the full story on AllPennyStocks.com, click here.

Seelos Therapeutics (NASDAQ:SEEL)
Gráfico Histórico do Ativo
De Dez 2024 até Jan 2025 Click aqui para mais gráficos Seelos Therapeutics.
Seelos Therapeutics (NASDAQ:SEEL)
Gráfico Histórico do Ativo
De Jan 2024 até Jan 2025 Click aqui para mais gráficos Seelos Therapeutics.